Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blood money.

S B Cohen1

  • 1UK Cord Blood Immunology Group, Royal Free School of Medicine/University College London.

Biologist (London, England)
|January 12, 2001
PubMed
Summary
This summary is machine-generated.

Foetal blood stem cells can regenerate blood and immune cells. This placental blood is a safe alternative to bone marrow for paediatric transplants and can be stored for future use, raising financial and ethical questions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of a machine learning tool for the early identification of patients with undiagnosed psoriatic arthritis - A retrospective population-based study.

Journal of translational autoimmunity·2023
Same author

Assessing vaccine-mediated protection in an ultra-low dose <i>Mycobacterium tuberculosis</i> murine model.

bioRxiv : the preprint server for biology·2023
Same author

Correction to: PANLAR consensus statement on biosimilars.

Clinical rheumatology·2019
Same author

PANLAR consensus statement on biosimilars.

Clinical rheumatology·2019
Same author

Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study.

Lupus·2016
Same author

Subunit vaccine H56/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung.

Mucosal immunology·2016
Same journal

Safe haven: REFUGEE BIOLOGISTS.

Biologist (London, England)·2015
Same journal

Chronobiology and chronomics: detecting and applying the cycles of nature.

Biologist (London, England)·2010
Same journal

Galls on thistles.

Biologist (London, England)·2003
Same journal

Biogeography, a dirty word?

Biologist (London, England)·2003
Same journal

Insect repellants in urban settings.

Biologist (London, England)·2003
Same journal

Ripe for a change.

Biologist (London, England)·2003
See all related articles

Area of Science:

  • Reproductive medicine
  • Haematology
  • Immunology

Background:

  • Foetal blood, sourced from the placenta, contains potent stem cells capable of regenerating all blood and immune system components.
  • This placental blood is a clinically established and safe alternative to bone marrow transplantation, particularly for paediatric patients.
  • Current research explores the possibility of storing foetal blood for autologous (self) use later in life.

Purpose of the Study:

  • To evaluate the potential of storing foetal blood for future autologous use.
  • To examine the implications of commercial interests in foetal blood banking.
  • To address the associated financial and ethical considerations.

Main Methods:

  • Review of current clinical applications of foetal blood stem cell transplantation.

Related Experiment Videos

  • Analysis of emerging technologies for foetal blood preservation and storage.
  • Ethical and financial impact assessment of private foetal blood banking.

    • Main Results:

    • Foetal blood stem cells are a viable alternative to bone marrow for paediatric transplantation.
    • Storage of foetal blood for future autologous use is technically feasible.
    • Commercialization of foetal blood banking presents significant financial and ethical challenges.

    Conclusions:

    • Placental-derived foetal blood stem cells offer a safe and effective source for regenerative medicine.
    • The storage of foetal blood for potential future use warrants careful consideration of ethical and financial implications.
    • Further research and clear regulatory frameworks are needed to navigate the commercialization of foetal blood banking.